Mathematical Model for Measles Virus Production in Batch Bioreactors
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Shiny Samuel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA. Hauptthemen laut MEDLINE: Measles virus, Bioreactors, Virus Cultivation, Models, Biological. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL): 70NANB17H002..
Abstract (Originalsprache)
Measles virus (MeV) is a promising vector for vaccines, gene therapy, and oncolytic virus therapy due to its safety, efficacy, and natural ability to target tumor cells. However, MeV production in bioreactors, typically with microcarrier cultures of Vero cells, is challenging because of the sensitivity of the virus to temperature, shear stress, and low pH. At 37°C, the optimal growth temperature of Vero cells, MeV has a short half‐life of 1 h, requiring precise control of the harvest time (TOH) to maximize yield. We developed a mathematical model to predict the TOH for recombinant MeV production in Vero cells. Model predictions for TOH were in good agreement with observations across five separate bioreactor runs, despite significant run‐to‐run performance variations. Parameter analysis revealed that virus attachment parameters and thermal degradation rate significantly influence infection dynamics. Furthermore, the model highlights the critical importance of accurately characterizing seed virus quality, particularly concerning defective interfering particle (DIP) content, to minimize production variability and optimize yield.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA.
ORCID-Profile: Todd Przybycien
Förderung
- National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL): 70NANB17H002.
Zitieren
APA
Samuel, S., & Przybycien, T. (2025). Mathematical Model for Measles Virus Production in Batch Bioreactors. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70017
Vancouver
Samuel S, Przybycien T. Mathematical Model for Measles Virus Production in Batch Bioreactors. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.70017
BibTeX
@article{Samuel2025,
author = {Samuel, Shiny and Przybycien, Todd},
title = {Mathematical Model for Measles Virus Production in Batch Bioreactors},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.70017}
}
EUVIMED